Obesity and endothelial function

Current Opinion in Endocrinology and Diabetes

Volumn 11, Issue 4, 2004, Pages 186-191

  Soodini, Geetha R ^a   Hamdy, Osama ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

Adipokines; Coronary artery disease; Endothelial function; Obesity; Visceral fat; Weight reduction

Indexed keywords

ADIPONECTIN; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET RESTRICTION; ENDOTHELIAL DYSFUNCTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; REVIEW; WEIGHT REDUCTION;

EID: 33645868492     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.med.0000140930.71370.36     Document Type: Review

References (52)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002, 288:1723-1727.
2. Mokdad AH, Serdula MK, Dietz WH, et al.: The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999, 282:1519-1522.
3. Mokdad AH, Bowman BA, Ford ES, et al.: The continuing epidemics of obesity and diabetes in the United Sates. JAMA 2001, 286:1195-1200.
4. Mokdad AH, Ford ES, Bowman BA, et al.: Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 2003, 289:76-79.
5. Caballero B: Obesity in developing countries: biological and ecological factors. J Nutr 2001, 131:866S-870S.
6. Dandona P: Endothelium, inflammation, and diabetes. Curr Diab Rep 2002, 2:311-315. Review article explaining the relationship between inflammation and diabetes.
7. Caballero AE: Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 2003, 11:1278-1289. Review article explaining the link between endothelial dysfunction and obesity.
8. McVeigh G, Conn J: Endothelial dysfunction and the metabolic syndrome. Curr Diab Rep 2003, 3:87-92.
9. Caballero-AE, Arora S, Saouaf R, et al.: Micro vascular and macro vascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999, 48:1856-1862. Excellent paper showing that the clock starts ticking early, long before diabetes is diagnosed in subjects at risk for type 2 diabetes.
10. Anderson TJ, Uehata A, Gerhard MD, et al.: Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26:1235-1241.
11. Tanko LB, Bagger YZ, Alexanderson P, et al.: Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 2003, 107:1623-1631. Large population-based study on postmenopausal women showing the antiatherogenic influence of peripheral fat mass and the importance of fat localization than obesity per se.
12. Van Pelt RE, Evans EM, Schechtman KB, et al.: Contributions of total and regional fat mass to risk of cardiovascular disease in older women. Am J Physiol Endocrinol Metab 2002, 282:E1023-E1228.
13. Ferreira I, Snijder MB, Twisk JW, van Mechelen W: Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study. J Clin Endocrinol Metab 2004, 89:2632-2639. Study done among apparently healthy adults showing the relationship between truncal and peripheral fat and large artery stiffness.
14. Chan DC, Watts GF, Barrett PH, Burke V: Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men. Q J Med 2003, 96:441-447. Study showing the importance of waist circumference as a surrogate marker of fat distribution.
15. Welborne TA, Dhaliwal SS, Bennett SA: Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med J Aust 2003, 179:580-585.
16. Dalton M, Cameron AJ, Zimmet PZ, et al.: Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 2003, 254:555-563. Study showing that waist-hip ratio is the most useful measure of obesity in identifying cardiovascular risk factors.
17. Bjorntorp P: Metabolic implications of body fat distribution. Diabetes Care 1991, 14:1132-1143.
18. Liu KH, Chan YL, Chan WB, et al.: Sonographic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes. Int J Obes 2003, 27:1267-1273. Excellent study showing that sonographic measurement of subcutaneous and visceral fat may potentially be a useful tool to evaluate regional distribution of obesity in the assessment of cardiovascular risk.
19. Bacha F, Saad R, Gungor N, et al.: Obesity, regional fat distribution, and syndrome x in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Endocrinol Metab 2003, 88:2534-2540.
20. Ratttarasan C, Leelawattana R, Soonthompun S, et al.: Regional abdominal fat distribution in lean and obese Thai type 2 diabetic women: relationships with insulin sensitivity and cardiovascular risk factors. Metabolism 2003, 52:1444-1447.
21. Gautier JF, Milner MR, Elam E, et al.: Visceral adipose tissue is not increased in Pima Indians compared with equally obese Caucasians and is not related to insulin action or secretion. Diabetologia 1999, 42:28-34.
22. Tanaguchi A, Nakai Y, Sakai M, et al.: Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Metabolism 2002, 51:544-548.
23. Maachi M, Pieroni L, Bruckert E, Jardel C, et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNF alpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004 [Epub ahead of print].
24. Jovinge S, Hamsten A, Tornvall P, et al.: Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism 1998, 47:113-118.
25. Patel JN, Jager A, Schalkwijk C, et al.: Effects of tumor necrosis factor-alpha in the human forearm: blood flow and endothelin-1 release. Clin Sci (Lond) 2002, 103:409-415.
26. Zeng M, Zhang H, Lowell C, He P: Tumor necrosis factor-alpha-induced leukocyte adhesion and microvessel permeability. Am J Physiol Heart Circ Physiol 2002, 283:H2420-H2430.
27. Ashton AW, Ware GM, Kaul DK, Ware JA: Inhibition of tumor necrosis factor alpha-mediated NFkappaB activation and leukocyte adhesion, with enhanced endothelial apoptosis, by G protein-linked receptor (TP) ligands. J Biol Chem 2003, 278:11858-11866.
28. Park SH, Park JH, Kang JS, Kang YH: Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression. Int J Biochem Cell Biol 2003, 35:168-182.
29. Uzui H, Harpf A, Liu M, et al.: Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation 2002, 106:3024-3030.
30. Yuan M, Konstantopoulos N, Lee J, et al.: Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ. Science 2001, 293:1673-1677.
31. Yudkin JS, Kumari M, Humphries M, Mohamed-Ali V: on behalf of the University College London Interleukin-6 group. Interleukin-6: a pro-inflammatory cytokine linking inflammation, obesity, stress, ethnicity, and coronary heart disease? Atherosclerosis 2000, 148:209-214.
32. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767-1772.
33. Suzuki K, Nakaji S, Yamada M, et al.: Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev 2002, 8:6-48.
34. Starkie R, Ostrowski SR, Jauffred S, et al.: Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J 2003, 17:884-886.
35. Okamoto Y, Kihara S, Ouchi N, et al.: Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002, 106:2767-2770.
36. Minamikawa J, Yamauchi M, Inoue D, Koshiyama H: Another potential use of troglitazone in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998, 83:1041-1042.
37. Matsuda M, Shimomura I, Sata M, et al.: Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002, 277:37487-37491.
38. Dzielinska Z, Januszewicz A, Wiecek A, et al.: Decreased plasma concentration of a novel anti-inflammatory protein-adiponectin-in hypertensive men with coronary artery disease. Thromb Res 2003, 110:365-369.
39. Ren J: Leptin and hyperleptinemia-from friend to foe for cardiovascular function. J Endocrinol 2004, 181:1-10.
40. Klein S, Fontana L, Young L, et al.: Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. New Engl J Med 2004, 350:2549-2557. An excellent study showing the absence of an effect of liposuction on cardiovascular risk factors suggesting that the type of fat that is removed may be of importance.
41. Mark AL, Correia ML, Rahmouni K, Haynes WG: Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 2002, 20:1245-1250.
42. Licinio J, Caglayan S, Ozata M, et al.: Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci USA 2004, 13:4531-4536.
43. Schulz C, Paulus K, Lehnert H: Central nervous and metabolic effects of intranasally applied leptin. Endocrinology 2004.
44. Moyna NM, Thompson PD: The effect of physical activity on endothelial function in man. Acta Physiol Scand 2004, 180:113-123.
45. Maiorana A, O'Driscoll G, Taylor R, Green D: Exercise and the nitric oxide vasodilator system. Sports Med 2003, 33:1013-1035.
46. Higashi Y, Yoshizumi M: Exercise and endothelial function: role of endothelium-derived nitric oxide and oxidative stress in healthy subjects and hypertensive patients. Pharmacol Ther 2004, 102:87-96.
47. Hamdy O, Ledbury S, Mullooly C, et al.: Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 2003, 26:2119-2125. Excellent study showing the effect of weight loss on endothelial function in obese subjects with and without diabetes.
48. Woo KS, Chook P, Yu CW, et al.: Effects of diet and exercise on obesity related vascular dysfunction in children. Circulation 2004, 109:1981-1986. Study showing the importance of physical activity in children.
49. Raitakari M, Ilvonen T, Ahotupa M, et al.: Weight reduction with very low calorie diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol 2004, 24:124-128. Study showing the effect of weight reduction on endothelial function.
50. Giugliano G, Nicoletti G, Grella E, et al.: Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg 2004, 57:190-194.
51. Gabriely I, Ma XH, Yang XM, et al.: Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 2002, 51:2951-2958.
52. Valsamakis G, McTernan PG, Chetty R, et al.: Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 2004, 53:430-434.